BX Swiss TOP 30 CHF
|
1 270,37
|
1,88
|
0,15 %
|
Analysen zu BX Swiss TOP 30 CHF-Werten
| 12.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.24 | Givaudan Hold | Deutsche Bank AG | |
| 12.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 11.04.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 11.04.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.04.24 | Givaudan Sell | UBS AG | |
| 11.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 11.04.24 | Givaudan Reduce | Baader Bank | |
| 11.04.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 10.04.24 | UBS Outperform | RBC Capital Markets | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 09.04.24 | Roche Neutral | UBS AG | |
| 09.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | Roche Equal Weight | Barclays Capital | |
| 08.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 04.04.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 04.04.24 | Richemont Buy | Jefferies & Company Inc. | |
| 04.04.24 | UBS Outperform | RBC Capital Markets | |
| 03.04.24 | Swiss Re Sell | UBS AG | |
| 03.04.24 | Givaudan Sell | UBS AG | |
| 03.04.24 | Swiss Re Hold | Jefferies & Company Inc. | |
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Givaudan Underweight | Barclays Capital | |
| 02.04.24 | Richemont Overweight | Barclays Capital | |
| 02.04.24 | Richemont Buy | UBS AG | |
| 02.04.24 | ABB Hold | Deutsche Bank AG | |
| 02.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 28.03.24 | Richemont Buy | Jefferies & Company Inc. | |
| 28.03.24 | UBS Outperform | RBC Capital Markets | |
| 28.03.24 | Richemont Sector Perform | RBC Capital Markets | |
| 28.03.24 | Novartis Underweight | Barclays Capital | |
| 27.03.24 | UBS Buy | Goldman Sachs Group Inc. |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.